Frank Greenway, M.D.

Professor--Chief Medical Officer


(225) 763-2578
(225) 763-3022
Send E-mail 


B.A. Stanford University, Stanford CA, 1966
M.D., University of California, Los Angeles, CA, 1970
Internal Medicine, Endocrinology/Metabolism, Harbor-UCLA Medical Center, Torrance CA, 1975


Dr. Greenway's area of interest is developing obesity treatments including diets, herbal supplements, medical foods, devices, obesity surgery and obesity drug development. He directs the outpatient research clinic.


Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;2;373(1):11-22.

Tam CS, Redman LM, Greenway F, LeBlanc KA, Haussmann MG, Ravussin E. Energy metabolic adaptation and cardiometablic improvements one year after gastric bypass, sleeve gastrectomy and gastric band. J Clin Endocrinol Metab. 2016;101(10):3755-67.

Marinos G, Eliades C, Raman Muthusamy V, Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10(5):929-34.

Liu AG, Most MM, Brashear MM, Johnson WD, Cefalu WT, Greenway FL. Reducing the glycemic index or carbohydrate content of mixed meals reduces posprandial glycemia and insulinemia over the entire day but does not affect satiety. Diabetes Care. 2012;35(8):1633-7.

Losso JN, Finley JW, Karki N, Liu AG, Prudente A, Tipton R, Yu y, Greenway FL. Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms. Am J Ther. 2018;25(2):e194-e201.

Twiner EM, Liu Z, Gimble J, Yu Y, Greenway F. Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix. Adv Ther. 2011;28(10):857-65.

Greenway FL, Fujioka K, Plodkowski RA, Mudalair S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-1 Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-1): a multicenere, randomized, double-blind, placebo-controlled, phase III trial. Lancet 2010;376(9741):595-605.
^ top